A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations

NCT02249936 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ardelyx

Collaborators